Because GBMs are known to be poorly immunogenic due to the downregulation of major histocompatibility complex (MHC) molecules (class I and II)57, we sought to determine the mechanism of MHC induction on GBM tumors, rendering them susceptible to T cell cytotoxicity. Here, HLA-C is linked to glioblastoma.